EVOLUS, INC. Deferred Income Tax Expense (Benefit)
EVOLUS, INC. (EOLS) reported Deferred Income Tax Expense (Benefit) of -$589.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-05
- EVOLUS, INC. deferred income tax expense (benefit) for the quarter ending 2026-06-30 was -$584.00K, a 3020.00% decline year-over-year.
- EVOLUS, INC. deferred income tax expense (benefit) for the quarter ending 2026-03-31 was -$5.00K.
- EVOLUS, INC. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was $27.00K.
- EVOLUS, INC. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was -$21.00K.
- EVOLUS, INC. deferred income tax expense (benefit) for fiscal 2025 was $21.00K.
- EVOLUS, INC. deferred income tax expense (benefit) for fiscal 2024 was -$21.00K, a 520.00% decline from fiscal 2023.
- EVOLUS, INC. deferred income tax expense (benefit) for fiscal 2023 was $5.00K.
- EVOLUS, INC. deferred income tax expense (benefit) for fiscal 2022 was -$18.00K, a 220.00% decline from fiscal 2021.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$584.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$589.00K 10-Q · filed 2026-08-05 | -$562.00K derived: sum of 3 quarters · filed 2026-08-05 | -$583.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$5.00K 10-Q · filed 2026-05-04 | $22.00K derived: sum of 2 quarters · filed 2026-05-04 | $1.00K derived: sum of 3 quarters · filed 2026-05-04 | $21.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $6.00K derived: sum of 2 quarters · filed 2026-03-03 | $26.00K derived: sum of 3 quarters · filed 2026-08-05 | $21.00K 10-K · filed 2026-03-03 |
| 2025-09-30 | -$21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.00K derived: sum of 2 quarters · filed 2026-08-05 | -$6.00K 10-Q · filed 2025-11-05 | -$29.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $15.00K 10-Q · filed 2026-08-05 | -$8.00K derived: sum of 3 quarters · filed 2026-08-05 | -$8.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$5.00K 10-Q · filed 2026-05-04 | -$28.00K derived: sum of 2 quarters · filed 2026-05-04 | -$28.00K derived: sum of 3 quarters · filed 2026-05-04 | -$31.00K derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$23.00K derived: sum of 2 quarters · filed 2026-03-03 | -$26.00K derived: sum of 3 quarters · filed 2026-03-03 | -$21.00K 10-K · filed 2026-03-03 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$3.00K derived: sum of 2 quarters · filed 2025-11-05 | $2.00K 10-Q · filed 2025-11-05 | $7.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $2.00K 10-Q · filed 2025-08-05 | $7.00K derived: sum of 3 quarters · filed 2026-03-03 | $7.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | $5.00K 10-Q · filed 2025-05-07 | $10.00K derived: sum of 2 quarters · filed 2026-03-03 | $10.00K derived: sum of 3 quarters · filed 2026-03-03 | $10.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $5.00K derived: sum of 2 quarters · filed 2026-03-03 | $5.00K derived: sum of 3 quarters · filed 2026-03-03 | $5.00K 10-K · filed 2026-03-03 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | -$3.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $0.00 10-Q · filed 2024-07-31 | -$3.00K derived: sum of 3 quarters · filed 2025-03-04 | -$7.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-07 | -$3.00K derived: sum of 2 quarters · filed 2025-03-04 | -$7.00K derived: sum of 3 quarters · filed 2025-03-04 | -$1.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2022-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$7.00K derived: sum of 2 quarters · filed 2025-03-04 | -$1.00K derived: sum of 3 quarters · filed 2025-03-04 | -$18.00K 10-K · filed 2025-03-04 |
| 2022-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $2.00K derived: sum of 2 quarters · filed 2023-11-07 | -$15.00K 10-Q · filed 2023-11-07 | $0.00 derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$11.00K 10-Q · filed 2023-08-02 | $4.00K derived: sum of 3 quarters · filed 2023-08-02 | $4.00K derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | -$17.00K 10-Q · filed 2023-05-09 | -$2.00K derived: sum of 2 quarters · filed 2023-05-09 | -$2.00K derived: sum of 3 quarters · filed 2023-05-09 | -$2.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $15.00K derived: sum of 2 quarters · filed 2023-03-08 | $15.00K derived: sum of 3 quarters · filed 2023-03-08 | $15.00K 10-K · filed 2023-03-08 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | -$154.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $0.00 10-Q · filed 2022-08-02 | -$154.00K derived: sum of 3 quarters · filed 2022-08-02 | -$165.00K derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | -$154.00K derived: sum of 2 quarters · filed 2022-05-10 | -$165.00K derived: sum of 3 quarters · filed 2022-05-10 | -$231.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$154.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$165.00K derived: sum of 2 quarters · filed 2022-03-03 | -$231.00K derived: sum of 3 quarters · filed 2022-03-03 | $25.00K 10-K · filed 2022-03-03 |
| 2020-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$77.00K derived: sum of 2 quarters · filed 2021-11-02 | $179.00K 10-Q · filed 2021-11-02 | $23.00K derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | -$66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $190.00K 10-Q · filed 2021-08-04 | $34.00K derived: sum of 3 quarters · filed 2021-08-04 | -$115.00K derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $256.00K 10-Q · filed 2021-05-12 | $100.00K derived: sum of 2 quarters · filed 2021-05-12 | -$49.00K derived: sum of 3 quarters · filed 2021-05-12 | -$276.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$305.00K derived: sum of 2 quarters · filed 2021-03-25 | -$532.00K derived: sum of 3 quarters · filed 2021-03-25 | -$15.05M 10-K · filed 2021-03-25 |
| 2019-09-30 | -$149.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$376.00K derived: sum of 2 quarters · filed 2020-10-29 | -$14.90M 10-Q · filed 2020-10-29 | -$14.88M derived: sum of 4 quarters · filed 2020-10-29 |
| 2019-06-30 | -$227.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$14.75M 10-Q · filed 2020-08-10 | -$14.73M derived: sum of 3 quarters · filed 2020-08-10 | -$14.71M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | -$14.52M 10-Q · filed 2020-05-11 | -$14.50M derived: sum of 2 quarters · filed 2020-05-11 | -$14.48M derived: sum of 3 quarters · filed 2020-05-11 | -$14.47M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $43.00K derived: sum of 2 quarters · filed 2020-02-25 | $55.00K derived: sum of 3 quarters · filed 2020-02-25 | $65.00K 10-K · filed 2020-02-25 |
| 2018-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $31.00K derived: sum of 2 quarters · filed 2019-11-04 | $41.00K 10-Q · filed 2019-11-04 | -$6.27M derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $22.00K 10-Q · filed 2019-08-12 | -$6.29M derived: sum of 3 quarters · filed 2019-08-12 | -$6.27M derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $10.00K 10-Q · filed 2019-05-01 | -$6.30M derived: sum of 2 quarters · filed 2019-05-01 | -$6.29M derived: sum of 3 quarters · filed 2019-05-01 | -$6.26M derived: sum of 4 quarters · filed 2019-05-01 |
| 2017-12-31 | -$6.31M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-20 | -$6.29M derived: sum of 2 quarters · filed 2019-03-20 | -$6.28M derived: sum of 3 quarters · filed 2019-03-20 | -$6.25M 10-K · filed 2019-03-20 |
| 2017-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $36.00K derived: sum of 2 quarters · filed 2018-11-05 | $56.00K 10-Q · filed 2018-11-05 | |
| 2017-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $40.00K 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | $20.00K 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |